Edwards Lifesciences (NYSE: EW) announced today that it provided the founding sponsorship for a new AHA Heart Valve ...

(HealthDay News) — The prevalence of moderate or greater valvular heart disease (VHD) in the United States is 8.2 percent, according to a study presented at the 2025 Transcatheter Cardiovascular ...

The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...